Ubs Group Ag Nu Cana PLC Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
SELL
$0.26 - $0.42 $52 - $84
-200 Reduced 57.14%
150 $0
Q4 2023

Feb 09, 2024
BUY
$0.26 - $0.8 $52 - $160
200 Added 133.33%
350 $0
Q3 2023

Nov 09, 2023
SELL
$0.58 - $0.86 $1,034 - $1,534
-1,784 Reduced 92.24%
150 $0
Q2 2023

Aug 11, 2023
BUY
$0.7 - $0.96 $1,248 - $1,712
1,784 Added 1189.33%
1,934 $1,000
Q1 2023

May 12, 2023
BUY
$0.76 - $1.69 $114 - $253
150 New
150 $0
Q3 2022

Nov 10, 2022
SELL
$0.62 - $26.13 $4,764 - $200,782
-7,684 Reduced 91.09%
752 $1,000
Q2 2022

Aug 10, 2022
BUY
$0.59 - $1.06 $4,977 - $8,942
8,436 New
8,436 $6,000
Q1 2022

May 16, 2022
SELL
$0.74 - $3.27 $2,080 - $9,191
-2,811 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$2.02 - $2.9 $5,678 - $8,151
2,811 New
2,811 $7,000
Q1 2021

May 12, 2021
SELL
$4.38 - $7.0 $7,923 - $12,663
-1,809 Closed
0 $0
Q4 2020

Feb 11, 2021
SELL
$4.4 - $5.59 $1,557 - $1,978
-354 Reduced 16.37%
1,809 $8,000
Q3 2020

Nov 12, 2020
BUY
$4.57 - $6.48 $9,884 - $14,016
2,163 New
2,163 $11,000
Q1 2020

May 01, 2020
SELL
$4.02 - $9.05 $1,981 - $4,461
-493 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$5.55 - $8.48 $3,968 - $6,063
-715 Reduced 59.19%
493 $3,000
Q3 2019

Nov 14, 2019
SELL
$6.95 - $10.71 $2,307 - $3,555
-332 Reduced 21.56%
1,208 $9,000
Q2 2019

Aug 14, 2019
BUY
$9.74 - $17.45 $14,999 - $26,873
1,540 New
1,540 $16,000
Q1 2019

May 14, 2019
SELL
$10.92 - $18.03 $9,358 - $15,451
-857 Closed
0 $0
Q4 2018

Feb 14, 2019
SELL
$13.0 - $22.57 $17,992 - $31,236
-1,384 Reduced 61.76%
857 $12,000
Q3 2018

Nov 14, 2018
BUY
$20.12 - $26.86 $41,004 - $54,740
2,038 Added 1003.94%
2,241 $56,000
Q2 2018

Aug 14, 2018
SELL
$19.0 - $29.84 $23,769 - $37,329
-1,251 Reduced 86.04%
203 $4,000
Q1 2018

May 15, 2018
BUY
$10.04 - $28.25 $14,598 - $41,075
1,454 New
1,454 $28,000

Others Institutions Holding NCNA

# of Institutions
1
Shares Held
3.33M
Call Options Held
0
Put Options Held
0
View Full List

About NuCana plc

NCNA Quotes by TradingView
  • Ticker NCNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,196,000
  • Market Cap $65.2M
  • Description
  • NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...
More about NCNA
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email